Calidi announced that its board of directors has approved the reverse stock split of its outstanding shares of common stock at a ratio of 1-for-10. The reverse stock split is expected to become effective at 12:01 a.m. Eastern Time on July 15. The company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on July 15 under the existing symbol. At the special meeting of stockholders held on June 6, the company’s stockholders approved the amendment to the company’s Certificate of Incorporation, as amended, to effect a reverse stock split of the company’s common stock at a ratio of not less than 1-for-10 and not more than 1-for-50, with the ratio to be determined by the company’s board of directors. On July 1, the board of directors approved the 1-for-10 ratio.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDI:
- Calidi initiated with a Buy at Ladenburg
- Calidi Biotherapeutics Welcomes Dr. George Peoples to Board
- Calidi enters collaboration with Siga Technologies to support RTNova development
- Calidi Biotherapeutics Enhances Funding Through Warrant Exercises
- Calidi Biotherapeutics Enhances Executive Compensation Package